Consolidated Edison Inc ED YTD Performance Shows Relative Sector Outperformance Narrow Peer Group Underperformance DLX Deluxe tops Q4 2025 EPS estimates by 141 percent shares climb 241 percent on upbeat investor sentiment Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval ORCL Oracle Corporation Q1 2026 EPS beats by 31 revenue surges 84 yearoveryear shares rise modestly